Canakinumab in combination with first-line (1L) pembrolizumab plus chemotherapy for advanced non-small cell lung cancer (aNSCLC): Results from the CANOPY-1 phase 3 trial.Daniel S. Tan,Enriqueta Felip,Gilberto Castro,Benjamin J. Solomon,Alastair Greystoke,Byoungchul Cho,Manuel Cobo,Tae Min Kim,Sandip Ganguly,Enric Carcereny, Luis Paz-Ares,Jaafar Bennouna,Marina Garassino,Michael Schenker,Sang-We Kim, Bijoyesh Mookerje,Vanessa Q. Passos,Stephanie Deudon,Bharani Dharan,Yuanbo Song,Rafael Caparica,Bruce E. JohnsonCANCER RESEARCH（2022）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
